Natesto (Endo Pharmaceuticals)


Welcome to the PulseAid listing for the Natesto drug offered from Endo Pharmaceuticals. This Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Endo Pharmaceuticals
NON-PROPRIETARY NAME: testosterone
SUBSTANCE NAME: TESTOSTERONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient]
ROUTE: NASAL
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-03-12
END MARKETING DATE: 2018-05-31


Natesto HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNatesto from Endo Pharmaceuticals
LABELER NAME: Endo Pharmaceuticals
DEA SCHEDULE: CIII
ACTIVE STRENGTH: 5.5(mg/1)
START MARKETING DATE: 2015-03-12
END MARKETING DATE: 2018-05-31
PRODUCT ID: 63481-239_f35f5567-366d-478f-bd2d-addcabebc0f6
PRODUCT NDC: 63481-239
APPLICATION NUMBER: NDA205488

Other TESTOSTERONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Androgel
Actavis Pharma, Inc.Testosterone
Allergan, Inc.Androderm
Apotheca CompanyTestosterone
Aytu BioScience, Inc.Natesto
Columbia Laboratories, Inc.Striant
Deseret Biologicals, Inc.Testosterone
Eli Lilly and CompanyAXIRON
Endo PharmaceuticalsNatesto
Endo Pharmaceuticals, Inc.FORTESTA
Par PharmaceuticalTestosterone
Par Pharmaceutical, Inc.Testosterone
Perrigo New York IncTestosterone
Physicians Total Care, Inc.Androgel
Prasco LaboratoriesTestosterone
Qualgen LLCTestosterone
Rebel Distributors Corp.Androgel
Slate PharmaTestopel
Stat Rx USATestim
Upsher-Smith Laboratories, Inc.Testosterone
Upsher-Smith Laboratories, LLCVogelxo
Zoe ProcessingTestosterone